MX349603B - Solucion oftalmica para tratar infeccion ocular que comprende levofloxacina o sal de la misma o solvato de la misma, metodo para tratar infeccion ocular, levofloxacina o sal de la misma o solvato de la misma, y uso de la misma. - Google Patents
Solucion oftalmica para tratar infeccion ocular que comprende levofloxacina o sal de la misma o solvato de la misma, metodo para tratar infeccion ocular, levofloxacina o sal de la misma o solvato de la misma, y uso de la misma.Info
- Publication number
- MX349603B MX349603B MX2012009844A MX2012009844A MX349603B MX 349603 B MX349603 B MX 349603B MX 2012009844 A MX2012009844 A MX 2012009844A MX 2012009844 A MX2012009844 A MX 2012009844A MX 349603 B MX349603 B MX 349603B
- Authority
- MX
- Mexico
- Prior art keywords
- levofloxacin
- dosage
- ophthalmic solution
- solvate
- salt
- Prior art date
Links
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 title abstract 8
- 229960003376 levofloxacin Drugs 0.000 title abstract 8
- 208000001860 Eye Infections Diseases 0.000 title abstract 5
- 208000011323 eye infectious disease Diseases 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 title 2
- 239000012453 solvate Substances 0.000 title 2
- 239000003889 eye drop Substances 0.000 title 1
- 229940012356 eye drops Drugs 0.000 title 1
- 229940054534 ophthalmic solution Drugs 0.000 abstract 5
- 239000002997 ophthalmic solution Substances 0.000 abstract 5
- 241000894006 Bacteria Species 0.000 abstract 3
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 201000007032 bacterial conjunctivitis Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229940114474 levofloxacin ophthalmic solution Drugs 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 238000004904 shortening Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010040281 | 2010-02-25 | ||
| PCT/JP2010/072685 WO2011104981A1 (ja) | 2010-02-25 | 2010-12-16 | レボフロキサシンもしくはその塩またはそれらの溶媒和物を含有する眼感染症治療用点眼剤、眼感染症の治療方法、レボフロキサシンもしくはその塩またはそれらの溶媒和物、ならびにその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2012009844A MX2012009844A (es) | 2012-09-21 |
| MX349603B true MX349603B (es) | 2017-08-03 |
Family
ID=44506417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012009844A MX349603B (es) | 2010-02-25 | 2010-12-16 | Solucion oftalmica para tratar infeccion ocular que comprende levofloxacina o sal de la misma o solvato de la misma, metodo para tratar infeccion ocular, levofloxacina o sal de la misma o solvato de la misma, y uso de la misma. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120316158A1 (enExample) |
| EP (1) | EP2540299B1 (enExample) |
| JP (3) | JP5600056B2 (enExample) |
| KR (2) | KR20130043611A (enExample) |
| CN (1) | CN102770141A (enExample) |
| BR (1) | BR112012021247A2 (enExample) |
| CA (1) | CA2791190C (enExample) |
| EA (1) | EA201290827A1 (enExample) |
| ES (1) | ES2568647T3 (enExample) |
| MX (1) | MX349603B (enExample) |
| MY (1) | MY183483A (enExample) |
| NZ (1) | NZ602126A (enExample) |
| PH (2) | PH12012501674A1 (enExample) |
| SG (1) | SG183427A1 (enExample) |
| TW (1) | TWI488627B (enExample) |
| WO (1) | WO2011104981A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2791190C (en) * | 2010-02-25 | 2017-12-12 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof |
| CN103550144B (zh) * | 2013-10-25 | 2015-10-14 | 深圳朗欧医药集团有限公司 | 盐酸左氧氟沙星组合物注射液及其制备方法 |
| JP6363833B2 (ja) * | 2013-11-22 | 2018-07-25 | ナノシータ株式会社 | 薄膜状高分子構造体 |
| CN104606198A (zh) * | 2015-01-09 | 2015-05-13 | 周元铎 | 盐酸左氧氟沙星在制备防治家蚕细菌性败血病药中的应用 |
| IT201900005280A1 (it) * | 2019-04-05 | 2020-10-05 | Ntc S R L | Composizione otologica |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3038722B2 (ja) | 1989-06-23 | 2000-05-08 | 日本電気株式会社 | 接合型電界効果トランジスタ |
| JP3192290B2 (ja) | 1993-08-04 | 2001-07-23 | カネボウ株式会社 | ポリエステル製耐熱ボトル |
| US7629458B2 (en) * | 2001-10-03 | 2009-12-08 | Teva Pharmaceutical Industries Ltd. | Preparation of levofloxacin and hemihydrate thereof |
| US7169792B2 (en) * | 2001-11-30 | 2007-01-30 | Lg Life Sciences Ltd. | Method of treating bacterial infections using gemifloxacin or a salt thereof and a β-lactam antibiotic |
| WO2005000307A1 (en) * | 2003-06-26 | 2005-01-06 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition containing quinolones and method of use |
| US20050009836A1 (en) | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
| JP2009526003A (ja) * | 2006-02-10 | 2009-07-16 | パーリ・ファルマ・ゲーエムベーハー | 吸入療法用噴霧状抗生物質 |
| WO2008005276A2 (en) * | 2006-06-30 | 2008-01-10 | Directcontact Llc | Growth factor delivery system containing antimicrobial agents |
| EP2143422A1 (en) * | 2008-07-11 | 2010-01-13 | S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. | Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections |
| CA2791190C (en) * | 2010-02-25 | 2017-12-12 | Santen Pharmaceutical Co., Ltd. | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof |
-
2010
- 2010-12-16 CA CA2791190A patent/CA2791190C/en not_active Expired - Fee Related
- 2010-12-16 KR KR1020127024069A patent/KR20130043611A/ko not_active Ceased
- 2010-12-16 EP EP10846644.2A patent/EP2540299B1/en not_active Not-in-force
- 2010-12-16 KR KR1020177015979A patent/KR20170070265A/ko not_active Ceased
- 2010-12-16 PH PH1/2012/501674A patent/PH12012501674A1/en unknown
- 2010-12-16 JP JP2010280325A patent/JP5600056B2/ja active Active
- 2010-12-16 WO PCT/JP2010/072685 patent/WO2011104981A1/ja not_active Ceased
- 2010-12-16 MX MX2012009844A patent/MX349603B/es active IP Right Grant
- 2010-12-16 MY MYPI2012003769A patent/MY183483A/en unknown
- 2010-12-16 US US13/580,931 patent/US20120316158A1/en not_active Abandoned
- 2010-12-16 SG SG2012061842A patent/SG183427A1/en unknown
- 2010-12-16 ES ES10846644.2T patent/ES2568647T3/es active Active
- 2010-12-16 NZ NZ602126A patent/NZ602126A/xx not_active IP Right Cessation
- 2010-12-16 BR BR112012021247-8A patent/BR112012021247A2/pt not_active Application Discontinuation
- 2010-12-16 CN CN2010800646540A patent/CN102770141A/zh active Pending
- 2010-12-16 PH PH1/2016/501747A patent/PH12016501747B1/en unknown
- 2010-12-16 EA EA201290827A patent/EA201290827A1/ru unknown
- 2010-12-28 TW TW099146206A patent/TWI488627B/zh not_active IP Right Cessation
-
2012
- 2012-03-12 JP JP2012054761A patent/JP2012162532A/ja active Pending
-
2013
- 2013-08-16 JP JP2013169146A patent/JP5674882B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PH12012501674A1 (en) | 2012-11-05 |
| PH12016501747A1 (en) | 2019-02-11 |
| WO2011104981A1 (ja) | 2011-09-01 |
| US20120316158A1 (en) | 2012-12-13 |
| SG183427A1 (en) | 2012-09-27 |
| JP5600056B2 (ja) | 2014-10-01 |
| JP2013241464A (ja) | 2013-12-05 |
| EP2540299A4 (en) | 2013-07-24 |
| PH12016501747B1 (en) | 2022-06-22 |
| CA2791190C (en) | 2017-12-12 |
| JP5674882B2 (ja) | 2015-02-25 |
| JP2011195564A (ja) | 2011-10-06 |
| EP2540299A1 (en) | 2013-01-02 |
| BR112012021247A2 (pt) | 2018-04-03 |
| CN102770141A (zh) | 2012-11-07 |
| MY183483A (en) | 2021-02-20 |
| CA2791190A1 (en) | 2011-09-01 |
| AU2010346703A1 (en) | 2012-09-20 |
| JP2012162532A (ja) | 2012-08-30 |
| EP2540299B1 (en) | 2016-04-13 |
| NZ602126A (en) | 2013-10-25 |
| TW201129364A (en) | 2011-09-01 |
| HK1177887A1 (en) | 2013-08-30 |
| EA201290827A1 (ru) | 2013-03-29 |
| KR20130043611A (ko) | 2013-04-30 |
| TWI488627B (zh) | 2015-06-21 |
| KR20170070265A (ko) | 2017-06-21 |
| ES2568647T3 (es) | 2016-05-03 |
| MX2012009844A (es) | 2012-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT201700192A (es) | Combinaciones de compuestos activos desde el punto de vista fungicida | |
| MY179292A (en) | Monobactam organic compounds for the treatment of bacterial infections | |
| CL2017000156A1 (es) | Procedimientos para el tratamiento de paramixovirus. | |
| SV2017005604A (es) | Derivados de 3-tetrazolil-benzeno-1,2-disulfonamida como inhibidores de la metallo-beta-lactamasa | |
| MX2017000408A (es) | Compuestos antiproliferativos y métodos de uso de los mismos. | |
| MX390503B (es) | Compuesto de pirimidina fusionada o sal del mismo. | |
| CO2017003838A2 (es) | Compuestos de aminopurina sustituida, composiciones del mismo, y métodos de tratamiento con los mismos | |
| MX2018005382A (es) | Compuestos de biaril-monobactam y metodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| UY35242A (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| MX2016004532A (es) | Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida. | |
| MX389999B (es) | Estabilizadores de mastocitos para el tratamiento de hipercitoquinemia e infeccion viral | |
| MX389545B (es) | Compuestos terapeuticos y composiciones para el tratamiento de trastornos sociales y trastornos de uso de sustancias. | |
| EA201790726A1 (ru) | Фармацевтическая композиция для лечения язвенного колита | |
| UY36447A (es) | Combinaciones de compuestos activos | |
| CR20170267A (es) | Combinaciones de compuestos activos | |
| CO2017006983A2 (es) | Una composición fungicida que comprende una n-ciclopropil- n-[bencilo sustituido]-3-(difluorometil)-5-fluoro-1- metil-1-h-pirazol-4-carboxamida o derivado de tiocarboxamida y dos compuestos fungicidas activos adicionales | |
| CR20170269A (es) | Combinaciones de compuestos activos | |
| GB2541840A (en) | Ophthalmic composition for the treatment of ocular infection | |
| CL2017001276A1 (es) | Derivados de benzotiazol antibacterianos | |
| MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
| MY183483A (en) | Ophthalmic solution for treating ocular infection comprising levofloxacin or salt thereof or solvate of the same, method for treating ocular infection, levofloxacin or salt thereof or solvate of the same, and use thereof | |
| BR112016018048A2 (pt) | Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto | |
| MX2017006476A (es) | Terapia de combinacion efectiva contra microorganismos, que incluye microorganismos resistentes a farmacos. | |
| MX2017015988A (es) | Derivados de manosa para tratar infecciones bacterianas. | |
| UY37397A (es) | Combinaciones de compuestos activos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |